Mutual Fund Data: Stock Market today Insights for – 26 Aug 2024

Below is a summary of the recent activities observed within the mutual fund for the clients: Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund. Let’s delve into the details below to explore further.

Company Logo	Company	Client Name	Buy/Sell	Qty Traded	Price	Trader Name
	Medplus Health Services	Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund	Buy	1M	616.00	Lavender Rose Investment
		Icici Prudential India Opportunities Fund	Buy	1M	616.00	Lavender Rose Investment
		Icici Prudential Innovation Fund	Buy	604K	616.00	Lavender Rose Investment
		Icici Prudential Multi-asset Fund	Buy	966K	616.00	Lavender Rose Investment
	Nitco	Jm Financial Asset Reconstruction Company	Sell	510K	90.83	Na

The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential Pharma Healthcare & Diagnostics (phd) Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 1M shares of Medplus Health Services have been purchased by the by Icici Prudential India Opportunities Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 604K shares of Medplus Health Services have been purchased by the by Icici Prudential Innovation Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 966K shares of Medplus Health Services have been purchased by the by Icici Prudential Multi-asset Fund through mutual funds at a price of ₹616.00 per shareand it is sold by Lavender Rose Investment at a price of ₹616.00 per share.
The 510K shares of Nitco have been sold by the by Jm Financial Asset Reconstruction Company through mutual funds at a price of ₹90.83 per share.

[my_shortcode values=”Medplus Health Services, Buy, Nitco”]

Join our telegram for more updates

Stay Updated with Our YouTube Videos